Clinical Trial Update: The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma [Phase 3]

View source ↗

Summary

The ABC-HCC trial is a Phase 3 study evaluating atezolizumab plus bevacizumab versus transarterial chemoembolization in intermediate-stage hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING